Edwards Lifesciences Return on Assets (ROA) Growth & History (EW)
Edwards Lifesciences's return on assets (roa) was 8.03% for fiscal 2025.
View full Edwards Lifesciences company overviewEdwards Lifesciences annual return on assets (roa) history
| Fiscal year | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 8.03% | −29.22 pp |
| 2024 | 2024-12-31 | 37.24% | +21.36 pp |
| 2023 | 2023-12-31 | 15.89% | −2.24 pp |
| 2022 | 2022-12-31 | 18.12% | −0.98 pp |
| 2021 | 2021-12-31 | 19.10% | — |
| 2010 | 2010-12-31 | 12.89% | — |
Edwards Lifesciences quarterly return on assets (roa)
| Fiscal quarter | Period ended | Return on assets (ROA) | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.35% | −27.82 pp |
| Q1 2026 | 2026-03-31 | 8.32% | −28.42 pp |
| Q4 2025 | 2025-12-31 | 8.03% | −29.22 pp |
| Q3 2025 | 2025-09-30 | 10.42% | −26.80 pp |
| Q2 2025 | 2025-06-30 | 35.17% | +19.75 pp |
| Q1 2025 | 2025-03-31 | 36.74% | +21.36 pp |
| Q4 2024 | 2024-12-31 | 37.24% | +21.36 pp |
| Q3 2024 | 2024-09-30 | 37.23% | +21.34 pp |
| Q2 2024 | 2024-06-30 | 15.42% | −0.52 pp |
| Q1 2024 | 2024-03-31 | 15.38% | −2.06 pp |
| Q4 2023 | 2023-12-31 | 15.89% | −2.24 pp |
| Q3 2023 | 2023-09-30 | 15.89% | — |
| Q2 2023 | 2023-06-30 | 15.94% | — |
| Q1 2023 | 2023-03-31 | 17.44% | — |
| Q4 2022 | 2022-12-31 | 18.12% | — |
| Q2 2011 | 2011-06-30 | 12.89% | — |
| Q1 2011 | 2011-03-31 | 13.21% | — |
Edwards Lifesciences return on assets (roa) trends
Between the periods ended 2010-12-31 and 2025-12-31, Edwards Lifesciences's return on assets (roa) decreased from 12.89% to 8.03%, a change of −4.86 percentage points. The latest reported quarter, Q2 2026, shows 7.35%.
What return on assets means
Return on assets measures profit relative to the assets used to generate it. It can help compare operating efficiency over time, although normal ROA differs substantially between asset-light and asset-intensive industries.
How return on assets is calculated
TickerStat calculates annual ROA as reported net income divided by average total assets. Quarterly observations use trailing-12-month net income and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Edwards Lifesciences source filings ↗